German Roadmap for large research infrastructures

Based on the evaluation report from the German Council of Science and Humanities (Wissenschaftsrat), the German Federal Ministry of Education and Research (BMBF) included EU-OPENSCREEN in its new Roadmap.

To celebrate the inclusion of EU-OPENSCREEN in the national Roadmap, a Minisymposium took place on Tuesday, 14 May 2013 at 1:00pm at Campus Berlin-Buch. The Agenda can be downloaded here.

Carl Zeiss Foundation supports interdisciplinary research consortium ChemBioMed

Carl Zeiss Foundation supports interdisciplinary research consortium ChemBioMed

Innovative research concept jointly initiated by the Mainz University Medical Center and the JGU Biology and Chemistry institutes receives funding of €1 million. 

The new interdisciplinary research consortium "Chemical BioMedicine" (ChemBioMed) seeks to extract new materials from natural sources, such as fungi and deep-sea sponges, which could help dissect disease mechanisms and prevent illnesses. The Carl Zeiss Foundation is supporting the innovative research collaboration between the University Medical Center Mainz and the Biology and Chemistry institutes of Johannes Gutenberg University Mainz (JGU) with €1 million. This sponsorship is being provided as part of the foundation's program "Promotion of University Research Structures."

You can view the full press release from September 2012 here.

Minister of Science and Technology of the PR China visits Open Access Platform

In the framework of the inauguration of the "Sino-German Year of Science and Education 2009 / 2010", the Minister of Research and Technology of the People's Republic of China, Professor Wan Gang, visited the Max Delbrück Center for Molecular Medicine (MDC) and the Leibniz-Institute for Molecular Pharmacology (FMP) on the Campus Berlin-Buch on 30 March 2009.

Prof. Wan, who studied engineering, received a doctorate from the University Clausthal-Zellerfeld in Germany and worked for several years in the development department of a German car manufacturer in Ingolstadt, showed a strong interest in the latest technologies in genome and drug development research. At the Berlin Institute for Medical Systems Biology (BIMSB) of the MDC, he visited the most advanced sequencing technologies, which can decipher several sequences at a time and which are used by researchers to study the function of genes. The BIMBS is supported with 7.5 M€ by the BMBF initiative “Innovation und Spitzenforschung in den neuen Ländern“ (2008 bis 2010) as well as with 4.38 M€ by the Berlin senate.

In the “Screening Unit” of the adjacent FMP (with participation of the MDC and the Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig), Prof. Wan learnt how researchers systematically search large compound libraries for small active molecules for the development of new drugs.

Furthermore, Prof. Wan visited a research group at the MDC, which studies the genetic causes of cardiovascular diseases.